Citi opens ‘positive catalyst watch’ on Zimmer Biomet into AAOS

Citi opened a “30-day positive catalyst watch” on shares of Zimmer Biomet heading into next week’s American Academy of Orthopaedic Surgeons meeting. The firm says Zimmer Biomet’s analyst event will focus on its pipeline. The company has moved out of the corporate restructuring depths and into the accelerating growth phase, the analyst tells investors in a research note. Citi keeps a Neutral rating on the shares.